Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07370584 · ClinicalTrials.gov registry record · Phase 1
A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults
A Phase 1 study of Safety Study, sponsored by iVeena Delivery Systems.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT07370584 is a Phase 1 study of Safety Study that is actively recruiting participants, run by iVeena Delivery Systems. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07370584, a Phase 1 study of Safety Study, is actively recruiting participants, sponsored by iVeena Delivery Systems.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.
Conditions Studied
Interventions
- DRUG IVMED-85 ophthalmic solution
- DRUG Vehicle Ophthalmic Solution
Study Locations (1)
Tennessee
- Total Eye Care, P.A. - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07370584
The ClinicalTrials.gov registry entry for NCT07370584 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is iVeena Delivery Systems, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Safety Study appearing as the primary indexed condition, and to 2 interventions - of which IVMED-85 ophthalmic solution is the first listed.
NCT07370584 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT07370584 about?
NCT07370584 is a clinical study titled "A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults". The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking...
What is the current status of trial NCT07370584?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2026-02-04. Estimated completion is 2026-07.
What conditions does trial NCT07370584 study?
This clinical trial studies the following conditions: Safety Study.
What interventions are being tested in trial NCT07370584?
The interventions under investigation include: IVMED-85 ophthalmic solution (DRUG), Vehicle Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT07370584?
This trial is sponsored by iVeena Delivery Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07370584 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.